Axsome Therapeutics, Inc.
AXSM
$121.91
$0.260.21%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -74.91M | -64.60M | -79.35M | -68.36M | -98.65M |
| Total Depreciation and Amortization | 2.07M | 2.06M | 1.99M | 1.83M | 1.74M |
| Total Amortization of Deferred Charges | 708.00K | 672.00K | 641.00K | 619.00K | 454.00K |
| Total Other Non-Cash Items | 33.13M | 38.21M | 23.72M | 19.25M | 62.67M |
| Change in Net Operating Assets | 12.80M | 5.03M | 22.88M | -6.81M | 3.43M |
| Cash from Operations | -26.20M | -18.63M | -30.11M | -53.47M | -30.36M |
| Capital Expenditure | -30.00K | -90.00K | -52.00K | -98.00K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -30.00K | -90.00K | -52.00K | -98.00K | -7.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -330.00K | -311.00K | -186.00K | -163.00K | -- |
| Issuance of Common Stock | 17.57M | 33.39M | 18.01M | 2.50M | 1.15M |
| Repurchase of Common Stock | -533.00K | -473.00K | -1.33M | -1.62M | -280.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.46M | -2.20M | -2.11M | -1.91M | -867.00K |
| Cash from Financing | 14.24M | 30.41M | 14.38M | -1.19M | -2.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.99M | 11.68M | -15.78M | -54.75M | -30.37M |
